Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Azurette

Last reviewed on RxList: 6/9/2020
Azurette Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

What is Azurette?

Azurette (desogestrel/ethinyl estradiol and ethinyl estradiol kit) is a combined oral contraceptive (COC) indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

What are the possible side effects of Azurette?

Azurette may cause serious side effects including:

Dosage for Azurette

The dose of Azurette tablets are taken without interruption as follows: One white tablet daily for 21 days, one light-green (inert) tablet daily for 2 days followed by 1 light-blue (ethinyl estradiol) tablet daily for 5 days. For all subsequent cycles, the patient then begins a new 28 tablet regimen on the next day after taking the last light-blue tablet.

Azurette In Children

Safety and efficacy of Azurette tablets have been established in women of reproductive age. Safety and efficacy are expected to be the same for postpubertal adolescents under the age of 16 and for users 16 years and older. Use of this product before menarche is not indicated.

What Drugs, Substances, or Supplements Interact with Azurette?

Azurette may interact with other medicines such as:

  • rifampin,
  • barbiturates,
  • phenylbutazone,
  • phenytoin sodium,
  • carbamazepine,
  • griseofulvin,
  • ampicillin,
  • tetracycline antibiotics,
  • lamotrigine, and
  • HCV drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir

Tell your doctor all medications and supplements you use.

Azurette During Pregnancy and Breastfeeding

Azurette is intended to prevent pregnancy and should not be used in women with known or suspected pregnancy. Small amounts of oral contraceptive steroids have been identified in the milk of nursing mothers and a few adverse effects on the child have been reported, including jaundice and breast enlargement. Oral contraceptives given in the postpartum period may interfere with lactation by decreasing the quantity and quality of breast milk. Breastfeeding mothers should be advised not to use oral contraceptives and to use other forms of contraception until they have completely weaned their children.

Additional Information

Our Azurette (desogestrel/ethinyl estradiol and ethinyl estradiol kit) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

Which of the following are methods for contraception? See Answer
Azurette Professional Information

SIDE EFFECTS

An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see WARNINGS section):

  • Thrombophlebitis and venous thrombosis with or without embolism
  • Arterial thromboembolism
  • Pulmonary embolism
  • Myocardial infarction
  • Cerebral hemorrhage
  • Cerebral thrombosis
  • Hypertension
  • Gallbladder disease
  • Hepatic adenomas or benign liver tumors

There is evidence of an association between the following conditions and the use of oral contraceptives:

  • Mesenteric thrombosis
  • Retinal thrombosis

The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:

  • Nausea
  • Vomiting
  • Gastrointestinal symptoms (such as abdominal cramps and bloating)
  • Breakthrough bleeding
  • Spotting
  • Change in menstrual flow
  • Amenorrhea
  • Temporary infertility after discontinuation of treatment
  • Edema
  • Melasma which may persist
  • Breast changes: tenderness, enlargement, secretion
  • Change in weight (increase or decrease)
  • Change in cervical erosion and secretion
  • Diminution in lactation when given immediately postpartum
  • Cholestatic jaundice
  • Migraine
  • Rash (allergic)
  • Mental depression
  • Reduced tolerance to carbohydrates
  • Vaginal candidiasis
  • Change in corneal curvature (steepening)
  • Intolerance to contact lenses

The following adverse reactions have been reported in users of oral contraceptives and the association has been neither confirmed nor refuted:

  • Pre-menstrual syndrome
  • Cataracts
  • Changes in appetite
  • Cystitis-like syndrome
  • Headache
  • Nervousness
  • Dizziness
  • Hirsutism
  • Loss of scalp hair
  • Erythema multiforme
  • Erythema nodosum
  • Hemorrhagic eruption
  • Vaginitis
  • Porphyria
  • Impaired renal function
  • Hemolytic uremic syndrome
  • Acne
  • Changes in libido
  • Colitis
  • Budd-Chiari syndrome

Read the entire FDA prescribing information for Azurette (Desogestrel/ethinyl Estradiol and Ethinyl Estradiol Tablets )

SLIDESHOW

Choosing Your Birth Control Method See Slideshow
Related Resources for Azurette

© Azurette Patient Information is supplied by Cerner Multum, Inc. and Azurette Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW